Interestingly, SPRY1 knockdown using siRNA in human GSCs decreases cell growth as well as a sphere-forming ability by repressing CD15 and CD133 expression, which have been used as markers for defining glioma stem cells. The gene discussed is PROM1; the disease is central nervous system cancer.